Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Thoratec Company Profile (NASDAQ:THOR)

Consensus Ratings for Thoratec (NASDAQ:THOR) (?)
Ratings Breakdown: 9 Hold Rating(s), 10 Buy Rating(s)
Consensus Rating:Buy (Score: 2.53)
Consensus Price Target: $32.64 (19.11% upside)

Current Analysts' Coverage Summary for Thoratec (NASDAQ:THOR)
Show:
DateFirmActionRatingPrice TargetDetailsShare
9/22/2014Wells Fargo & Co.Reiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
8/25/2014Piper JaffrayDowngradeOverweight -> Neutral$40.00 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
8/20/2014WallachBeth CapitalLower Price TargetHold$38.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
8/11/2014Northland SecuritiesDowngradeOutperform -> Market Perform$46.00 -> $26.00ViewTweet This Rating  Share This Rating on StockTwits
8/8/2014ZacksReiterated RatingNeutral -> Neutral$24.00ViewTweet This Rating  Share This Rating on StockTwits
8/8/2014Canaccord GenuityReiterated RatingBuy$39.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
8/7/2014Bank of AmericaDowngradeNeutralViewTweet This Rating  Share This Rating on StockTwits
8/7/2014Raymond JamesReiterated RatingOutperform$41.00 -> $30.00ViewTweet This Rating  Share This Rating on StockTwits
8/7/2014Leerink SwannReiterated RatingOutperform$40.00 -> $35.00ViewTweet This Rating  Share This Rating on StockTwits
8/7/2014OppenheimerLower Price TargetOutperform$41.00 -> $35.00ViewTweet This Rating  Share This Rating on StockTwits
8/7/2014BTIG ResearchDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
8/7/2014Credit SuisseDowngradeOutperform -> Neutral$40.00 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
8/7/2014Goldman SachsDowngradeBuy -> Neutral$38.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
7/8/2014TheStreetUpgradeHold -> BuyViewTweet This Rating  Share This Rating on StockTwits
7/3/2014JPMorgan Chase & Co.Reiterated RatingNeutral$31.00 -> $35.00ViewTweet This Rating  Share This Rating on StockTwits
5/7/2014Citigroup Inc.Reiterated RatingOverweight$45.00 -> $43.00ViewTweet This Rating  Share This Rating on StockTwits
4/28/2014Ned Davis ResearchUpgradeNeutral -> BuyViewTweet This Rating  Share This Rating on StockTwits
10/31/2013BarclaysBoost Price TargetOverweight$43.00 -> $45.00ViewTweet This Rating  Share This Rating on StockTwits
10/31/2013Northland Capital PartnersBoost Price TargetOutperform$42.00 -> $46.00ViewTweet This Rating  Share This Rating on StockTwits
6/10/2013ArgusBoost Price TargetBuy$44.00 -> $53.00ViewTweet This Rating  Share This Rating on StockTwits
5/13/2013Lazard LtdDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
4/5/2013SidotiInitiated CoverageNeutralViewTweet This Rating  Share This Rating on StockTwits
3/13/2013William BlairInitiated CoverageMarket PerformViewTweet This Rating  Share This Rating on StockTwits
10/4/2012WedbushUpgradeNeutral -> OutperformViewTweet This Rating  Share This Rating on StockTwits
(Data available from 9/30/2012 forward)
Discuss Thoratec